Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Abbott reveals new motilides

Feb. 23, 1998

New gastrointestinal agents reported by Yoshitomi

Feb. 19, 1998

Enrollment complete for hepatitis C vaccine phase I trial

Feb. 19, 1998

Endorex licenses oral hepatitis B vaccine technology

Feb. 19, 1998

Bio-Technology General licenses hepatitis B vaccine

Feb. 17, 1998

JB-9315: a new H2 antagonist with both antisecretory and cytoprotective properties

Feb. 16, 1998

Plant extract DA-9601 protects against NSAID-induced gastric damage

Feb. 12, 1998

New agents for IBS from Nippon Shinyaku

Feb. 11, 1998

Maxamine/Infergen combination to be tested in clinic

Feb. 9, 1998

EMEA decision on Zacutex MAA deferred

Feb. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...